Computational tools for epitope vaccine design and evaluation

Current Opinion in Virology

Volumn 11, Issue , 2015, Pages 103-112

  He, Linling ^a   Zhu, Jiang ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; VACCINE; ANTIGEN;

ANTIBODY RESPONSE; ARTICLE; BIOINFORMATICS; CLINICAL TRIAL (TOPIC); CONSENSUS; DRUG DESIGN; DRUG SCREENING; DRUG STRUCTURE; HUMAN; MATHEMATICAL PHENOMENA; NONHUMAN; PRIORITY JOURNAL; PROTEIN STRUCTURE; QUANTITATIVE ANALYSIS; UNSPECIFIED SIDE EFFECT; ANIMAL; BIOLOGY; DRUG DEVELOPMENT; GENETICS; IMMUNOLOGICAL TECHNIQUE; IMMUNOLOGY; ISOLATION AND PURIFICATION; PROCEDURES; PROTEIN ENGINEERING;

ANIMALS; ANTIGENS; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; EPITOPES; HUMANS; IMMUNOLOGIC TECHNIQUES; PROTEIN ENGINEERING; VACCINES;

EID: 84961289547     PISSN: 18796257     EISSN: 18796265     Source Type: Journal    
DOI: 10.1016/j.coviro.2015.03.013     Document Type: Review

References (100)

1. G.J. Nabel Designing tomorrow's vaccines N Engl J Med 368 2013 551 560
2. R. Rappuoli, C.W. Mandl, S. Black, and E. De Gregorio Vaccines for the twenty-first century society Nat Rev Immunol 11 2011 865 872
3. P.D. Kwong, J.R. Mascola, and G.J. Nabel Broadly neutralizing antibodies and the search for an HIV-1 vaccine: the end of the beginning Nat Rev Immunol 13 2013 693 701
4. L.M. Walker, and D.R. Burton Rational antibody-based HIV-1 vaccine design: current approaches and future directions Curr Opin Immunol 22 2010 358 366
5. B.F. Haynes, G. Kelsoe, S.C. Harrison, and T.B. Kepler B-cell-lineage immunogen design in vaccine development with HIV-1 as a case study Nat Biotechnol 30 2012 423 433
6. F. Klein, H. Mouquet, P. Dosenovic, J.F. Scheid, L. Scharf, and M.C. Nussenzweig Antibodies in HIV-1 vaccine development and therapy Science 341 2013 1199 1204
7. J. Huang, G. Ofek, L. Laub, M.K. Louder, N.A. Doria-Rose, N.S. Longo, H. Imamichi, R.T. Bailer, B. Chakrabarti, and S.K. Sharma Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Nature 491 2012 406 412
8. J.S. McLellan, M. Pancera, C. Carrico, J. Gorman, J.-P. Julien, R. Khayat, R. Louder, R. Pejchal, M. Sastry, and K. Dai Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 Nature 480 2011 336 343
9. T. Zhou, I. Georgiev, X. Wu, Z.-Y. Yang, K. Dai, A. Finzi, Y.D. Kwon, J.F. Scheid, W. Shi, and L. Xu Structural basis for broad and potent neutralization of HIV-1 by antibody VRC01 Science 329 2010 811 817
10. T. Zhou, L. Xu, B. Dey, A.J. Hessell, D. Van Ryk, S.-H. Xiang, X. Yang, M.-Y. Zhang, M.B. Zwick, and J. Arthos Structural definition of a conserved neutralization epitope on HIV-1 gp120 Nature 445 2007 732 737
11. L. Scharf, J.F. Scheid, J.H. Lee, A.P. West, C. Chen, H. Gao, P.N.P. Gnanapragasam, R. Mares, M.S. Seaman, and A.B. Ward Antibody 8ANC195 reveals a site of broad vulnerability on the HIV-1 envelope spike Cell Rep 7 2014 785 795
12. R. Pejchal, K.J. Doores, L.M. Walker, R. Khayat, P.-S. Huang, S.-K. Wang, R.L. Stanfield, J.-P. Julien, A. Ramos, and M. Crispin A potent and broad neutralizing antibody recognizes and penetrates the HIV glycan shield Science 334 2011 1097 1103
13. M.G. Joyce, M. Kanekiyo, L. Xu, C. Biertuempfel, J.C. Boyington, S. Moquin, W. Shi, X. Wu, Y. Yang, and Z.-Y. Yang Outer domain of HIV-1 gp120: antigenic optimization, structural malleability, and crystal structure with antibody VRC-PG04 J Virol 87 2013 2294 2306
14. C. Blattner, J.H. Lee, K. Sliepen, R. Derking, E. Falkowska, A.T. de la Pena, A. Cupo, J.-P. Julien, M. van Gils, and P.S. Lee Structural delineation of a quaternary, cleavage-dependent epitope at the gp41-gp120 interface on intact HIV-1 Env trimers Immunity 40 2014 669 680
15. J.-P. Julien, A. Cupo, D. Sok, R.L. Stanfield, D. Lyumkis, M.C. Deller, P.-J. Klasse, D.R. Burton, R.W. Sanders, and J.P. Moore Crystal structure of a soluble cleaved HIV-1 envelope trimer Science 342 2013 1477 1483
16. D. Lyumkis, J.-P. Julien, N. de Val, A. Cupo, C.S. Potter, P.-J. Klasse, D.R. Burton, R.W. Sanders, J.P. Moore, and B. Carragher Cryo-EM structure of a fully glycosylated soluble cleaved HIV-1 envelope trimer Science 342 2013 1484 1490
17. M. Pancera, T. Zhou, A. Druz, I.S. Georgiev, C. Soto, J. Gorman, J. Huang, P. Acharya, G.Y. Chuang, and G. Ofek Structure and immune recognition of trimeric pre-fusion HIV-1 Env Nature 514 2014 455 461
18. N.A. Doria-Rose, C.A. Schramm, J. Gorman, P.L. Moore, J.N. Bhiman, B.J. DeKosky, M.J. Ernandes, I.S. Georgiev, H.J. Kim, and M. Pancera Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Nature 509 2014 55 62
19. D. Sok, U. Laserson, J. Laserson, Y. Liu, F. Vigneault, J.-P. Julien, B. Briney, A. Ramos, K.F. Saye, and K. Le The effects of somatic hypermutation on neutralization and binding in the PGT121 family of broadly neutralizing HIV antibodies PLoS Pathog 9 2013 e1003754
20. X. Wu, T. Zhou, J. Zhu, B. Zhang, I. Georgiev, C. Wang, X. Chen, N.S. Longo, M. Louder, and K. McKee Focused evolution of HIV-1 neutralizing antibodies revealed by structures and deep sequencing Science 333 2011 1593 1602
21. T. Zhou, J. Zhu, X. Wu, S. Moquin, B. Zhang, P. Acharya, I.S. Georgiev, H.R. Altae-Tran, G.-Y. Chuang, and M.G. Joyce Multidonor analysis reveals structural elements, genetic determinants, and maturation pathway for HIV-1 neutralization by VRC01-class antibodies Immunity 39 2013 245 258
22. J. Zhu, S. O'Dell, G. Ofek, M. Pancera, X. Wu, B. Zhang, Z. Zhang, J.C. Mullikin, M. Simek, and D.R. Burton Somatic populations of PGT135-137 HIV-1-neutralizing antibodies identified by 454 pyrosequencing and bioinfornnatics Front Microbiol 3 2012 315
23. J. Zhu, G. Ofek, Y. Yang, B. Zhang, M.K. Louder, G. Lu, K. McKee, M. Pancera, J. Skinner, and Z. Zhang Mining the antibodyome for HIV-1-neutralizing antibodies with next-generation sequencing and phylogenetic pairing of heavy/light chains Proc Natl Acad Sci U S A 110 2013 6470 6475
24. J. Zhu, X. Wu, B. Zhang, K. McKee, S. O'Dell, C. Soto, T. Zhou, J.P. Casazza, J.C. Mullikin, and P.D. Kwong De novo identification of VRC01 class HIV-1-neutralizing antibodies by next-generation sequencing of B-cell transcripts Proc Natl Acad Sci U S A 110 2013 E4088 E4097
25. B.E. Correia, Ban Y-EA, D.J. Friend, K. Ellingson, H. Xu, E. Boni, T. Bradley-Hewitt, J.F. Bruhn-Johannsen, L. Stamatatos, and R.K. Strong Computational protein design using flexible backbone remodeling and resurfacing: case studies in structure-based antigen design J Mol Biol 405 2011 284 297
26. B.E. Correia, Ban Y-EA, M.A. Holmes, H. Xu, K. Ellingson, Z. Kraft, C. Carrico, E. Boni, D.N. Sather, and C. Zenobia Computational design of epitope-scaffolds allows induction of antibodies specific for a poorly immunogenic HIV vaccine epitope Structure 18 2010 1116 1126
27. M.L. Azoitei, Ban Y-EA, J.-P. Julien, S. Bryson, A. Schroeter, O. Kalyuzhniy, J.R. Porter, Y. Adachi, D. Baker, and E.F. Pai Computational design of high-affinity epitope scaffolds by backbone grafting of a linear epitope J Mol Biol 415 2012 175 192
28. G. Ofek, F.J. Guenaga, W.R. Schief, J. Skinner, D. Baker, R. Wyatt, and P.D. Kwong Elicitation of structure-specific antibodies by epitope scaffolds Proc Natl Acad Sci U S A 107 2010 17880 17887
29. M.L. Azoitei, B.E. Correia, Ban Y-EA, C. Carrico, O. Kalyuzhniy, L. Chen, A. Schroeter, P.-S. Huang, J.S. McLellan, and P.D. Kwong Computation-guided backbone grafting of a discontinuous motif onto a protein scaffold Science 334 2011 373 376
30. B.E. Correia, J.T. Bates, R.J. Loomis, G. Baneyx, C. Carrico, J.G. Jardine, P. Rupert, C. Correnti, O. Kalyuzhniy, and V. Vittal Proof of principle for epitope-focused vaccine design Nature 507 2014 201 206
31. Y. Zhang Progress and challenges in protein structure prediction Curr Opin Struct Biol 18 2008 342 348
32. D. Baker, and A. Sali Protein structure prediction and structural genomics Science 294 2001 93 96
33. K. Ginalski Comparative modeling for protein structure prediction Curr Opin Struct Biol 16 2006 172 177
34. M.A. Marti-Renom, A.C. Stuart, A. Fiser, R. Sanchez, F. Melo, and A. Sali Comparative protein structure modeling of genes and genomes Annu Rev Biophys Biomol Struct 29 2000 291 325
35. D. Petrey, and B. Honig Protein structure prediction: inroads to biology Mol Cell 20 2005 811 819
36. K.A. Dill, S.B. Ozkan, M.S. Shell, and T.R. Weikl The protein folding problem Annu Rev Biophys 37 2008 289 316
37. M. Levitt, M. Gerstein, E. Huang, S. Subbiah, and J. Tsai Protein folding: the endgame Annu Rev Biochem 66 1997 549 579
38. R. Das, and D. Baker Macromolecular modeling with Rosetta Annu Rev Biochem 77 2008 363 382
39. C.A. Rohl, C.E.M. Strauss, K.M.S. Misura, and D. Baker Protein structure prediction using Rosetta Methods Enzymol 383 2004 66 93
40. A. Roy, A. Kucukural, and Y. Zhang I-TASSER: a unified platform for automated protein structure and function prediction Nat Protoc 5 2010 725 738
41. Y. Zhang I-TASSER server for protein 3D structure prediction BMC Bioinformatics 9 2008 40
42. D. Chivian, D.E. Kim, L. Malmstrom, P. Bradley, T. Robertson, P. Murphy, C.E.M. Strauss, R. Bonneau, C.A. Rohl, and D. Baker Automated prediction of CASP-5 structures using the Robetta server Proteins 53 2003 524 533
43. Y. Zhang Template-based modeling and free modeling by I-TASSER in CASP7 Proteins 69 2007 108 117
44. D. Kihara, H. Chen, and Y.D. Yang Quality assessment of protein structure models Curr Protein Pept Sci 10 2009 216 228
45. A. Kryshtafovych, and K. Fidelis Protein structure prediction and model quality assessment Drug Discov Today 14 2009 386 393
46. A. Kryshtafovych, A. Barbato, K. Fidelis, B. Monastyrskyy, T. Schwede, and A. Tramontano Assessment of the assessment: evaluation of the model quality estimates in CASP10 Proteins 82 2014 112 126
47. S.M. Lippow, and B. Tidor Progress in computational protein design Curr Opin Biotechnol 18 2007 305 311
48. S. Park, Y. Xi, and J.G. Saven Advances in computational protein design Curr Opin Struct Biol 14 2004 487 494
49. J.G. Saven Combinatorial protein design Curr Opin Struct Biol 12 2002 453 458
50. A.G. Street, and S.L. Mayo Computational protein design Struct Fold Des 7 1999 R105 R109
51. D.B. Gordon, S.A. Marshall, and S.L. Mayo Energy functions for protein design Curr Opin Struct Biol 9 1999 509 513
52. C.L. Vizcarra, and S.L. Mayo Electrostatics in computational protein design Curr Opin Chem Biol 9 2005 622 626
53. A.M. Poole, and R. Ranganathan Knowledge-based potentials in protein design Curr Opin Struct Biol 16 2006 508 513
54. J.R. Desjarlais, and N.D. Clarke Computer search algorithms in protein modification and design Curr Opin Struct Biol 8 1998 471 475
55. R.L. Dunbrack Rotamer libraries in the 21(st) century Curr Opin Struct Biol 12 2002 431 440
56. S.C. Lovell, J.M. Word, J.S. Richardson, and D.C. Richardson The penultimate rotamer library Proteins 40 2000 389 408
57. A.A. Canutescu, A.A. Shelenkov, and R.L. Dunbrack A graph-theory algorithm for rapid protein side-chain prediction Protein Sci 12 2003 2001 2014
58. Z.X. Xiang, and B. Honig Extending the accuracy limits of prediction for side-chain conformations J Mol Biol 311 2001 421 430
59. D. Kuroda, H. Shirai, M.P. Jacobson, and H. Nakamura Computer-aided antibody design Protein Eng Des Sel 25 2012 507 521
60. J.A. Caravella, D. Wang, S.M. Glaser, and A. Lugovskoy Structure-guided design of antibodies Curr Comput Aided Drug Des 6 2010 128 138
61. L.A. Clark, P.A. Boriack-Sjodin, J. Eldredge, C. Fitch, B. Friedman, K.J.M. Hanf, M. Jarpe, S.F. Liparoto, Y. Li, and A. Lugovskoy Affinity enhancement of an in vivo matured therapeutic antibody using structure-based computational design Protein Sci 15 2006 949 960
62. S.M. Lippow, K.D. Wittrup, and B. Tidor Computational design of antibody-affinity improvement beyond in vivo maturation Nat Biotechnol 25 2007 1171 1176
63. D.J. Mandell, and T. Kortemme Backbone flexibility in computational protein design Curr Opin Biotechnol 20 2009 420 428
64. G.D. Friedland, and T. Kortemme Designing ensembles in conformational and sequence space to characterize and engineer proteins Curr Opin Struct Biol 20 2010 377 384
65. X. Wu, Z.-Y. Yang, Y. Li, C.-M. Hogerkorp, W.R. Schief, M.S. Seaman, T. Zhou, S.D. Schmidt, L. Wu, and L. Xu Rational design of envelope identifies broadly neutralizing human monoclonal antibodies to HIV-1 Science 329 2010 856 861
66. R.J. Woods, and M.B. Tessier Computational glycoscience: characterizing the spatial and temporal properties of glycans and glycan-protein complexes Curr Opin Struct Biol 20 2010 575 583
67. M. Frank, and S. Schloissnig Bioinformatics and molecular modeling in glycobiology Cell Mol Life Sci 67 2010 2749 2772
68. E. Fadda, and R.J. Woods Molecular simulations of carbohydrates and protein-carbohydrate interactions: motivation, issues and prospects Drug Discov Today 15 2010 596 609
69. D.R. Burton Scaffolding to build a rational vaccine design strategy Proc Natl Acad Sci U S A 107 2010 17859 17860
70. D.J. Craik, M. Cemazar, and N.L. Daly The cyclotides and related macrocyclic peptides as scaffolds in drug design Curr Opin Drug Discov Dev 9 2006 251 260
71. D.J. Craik, S. Simonsen, and N.L. Daly The cyclotides: novel macrocyclic peptides as scaffolds in drug design Curr Opin Drug Discov Dev 5 2002 251 260
72. M.T. Stumpp, H.K. Binz, and P. Amstutz DARPins: a new generation of protein therapeutics Drug Discov Today 13 2008 695 701
73. R. Jefferis The antibody paradigm: present and future development as a scaffold for biopharmaceutical drugs Biotechnol Genet Eng Rev 26 2010 1 42
74. A.R. Ortiz, C.E.M. Strauss, and O. Olmea MAMMOTH (matching molecular models obtained from theory): an automated method for model comparison Protein Sci 11 2002 2606 2621
75. J.S. McLellan, B.E. Correia, M. Chen, Y. Yang, B.S. Graham, W.R. Schief, and P.D. Kwong Design and characterization of epitope-scaffold immunogens that present the motavizumab epitope from respiratory syncytial virus J Mol Biol 409 2011 853 866
76. T. Zhou, J. Zhu, Y. Yang, J. Gorman, G. Ofek, S. Srivatsan, A. Druz, C.R. Lees, G. Lu, and C. Soto Transplanting supersites of HIV-1 vulnerability PLOS ONE 9 2014 e99881
77. Y. Zhang, and J. Skolnick TM-align: a protein structure alignment algorithm based on the TM-score Nucleic Acids Res 33 2005 2302 2309
78. H. Hasegawa, and L. Holm Advances and pitfalls of protein structural alignment Curr Opin Struct Biol 19 2009 341 348
79. K. Ginalski, A. Elofsson, D. Fischer, and L. Rychlewski 3D-Jury: a simple approach to improve protein structure predictions Bioinformatics 19 2003 1015 1018
80. D. Fischer 3D-SHOTGUN: a novel, cooperative, fold-recognition meta-predictor Proteins 51 2003 434 441
81. Y. Yang, J. Zhan, H. Zhao, and Y. Zhou A new size-independent score for pairwise protein structure alignment and its application to structure classification and nucleic-acid binding prediction Proteins 80 2012 2080 2088
82. M.N. Nguyen, K.P. Tan, and M.S. Madhusudhan CLICK-topology-independent comparison of biomolecular 3D structures Nucleic Acids Res 39 2011 W24 W28
83. J.H. Zhu, and Z.P. Weng FAST: a novel protein structure alignment algorithm Proteins 58 2005 618 627
84. G. Wang, and R.L. Dunbrack PISCES: a protein sequence culling server Bioinformatics 19 2003 1589 1591
85. A. Andreeva, D. Howorth, J.M. Chandonia, S.E. Brenner, T.J.P. Hubbard, C. Chothia, and A.G. Murzin Data growth and its impact on the SCOP database: new developments Nucleic Acids Res 36 2007 419 425
86. A.L. Cuff, I. Sillitoe, T. Lewis, O.C. Redfern, R. Garratt, J. Thornton, and C.A. Orengo The CATH classification revisited - architectures reviewed and new ways to characterize structural divergence in superfamilies Nucleic Acids Res 37 2009 D310 D314
87. R.D. Finn, J. Mistry, J. Tate, P. Coggill, A. Heger, J.E. Pollington, O.L. Gavin, P. Gunasekaran, G. Ceric, and K. Forslund The Pfam protein families database Nucleic Acids Res 38 2010 D211 D222
88. L. Holm, and P. Rosenstrom Dali server: conservation mapping in 3D Nucleic Acids Res 38 2010 W545 W549
89. J. Peng, and J. Xu A multiple-template approach to protein threading Proteins 79 2011 1930 1939
90. L. Kong, E. Giang, J.B. Robbins, R.L. Stanfield, D.R. Burton, I.A. Wilson, and M. Law Structural basis of hepatitis C virus neutralization by broadly neutralizing antibody HCV1 Proc Natl Acad Sci U S A 109 2012 9499 9504
91. W.A. Rodriguez-Limas, K. Sekar, and K.E.J. Tyo Virus-like particles: the future of microbial factories and cell-free systems as platforms for vaccine development Curr Opin Biotechnol 24 2013 1089 1093
92. E.V.L. Grgacic, and D.A. Anderson Virus-like particles: passport to immune recognition Methods 40 2006 60 65
93. C. Ludwig, and R. Wagner Virus-like particles - universal molecular toolboxes Curr Opin Biotechnol 18 2007 537 545
94. G.T. Jennings, and M.F. Bachmann Coming of age of virus-like particle vaccines Biol Chem 389 2008 521 536
95. J. Jardine, J.-P. Julien, S. Menis, T. Ota, O. Kalyuzhniy, A. McGuire, D. Sok, P.-S. Huang, S. MacPherson, and M. Jones Rational HIV immunogen design to target specific germline B cell receptors Science 340 2013 711 716
96. M. Kanekiyo, C.-J. Wei, H.M. Yassine, P.M. McTamney, J.C. Boyington, J.R.R. Whittle, S.S. Rao, W.-P. Kong, L. Wang, and G.J. Nabel Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies Nature 498 2013 102 106
97. G. Georgiou, G.C. Ippolito, J. Beausang, C.E. Busse, H. Wardemann, and S.R. Quake The promise and challenge of high-throughput sequencing of the antibody repertoire Nat Biotechnol 32 2014 158 168
98. W.C. Koff, D.R. Burton, P.R. Johnson, B.D. Walker, C.R. King, G.J. Nabel, R. Ahmed, M.K. Bhan, and S.A. Plotkin Accelerating next-generation vaccine development for global disease prevention Science 340 2013 1232910
99. W.C. Koff, I.D. Gust, and S.A. Plotkin Toward a human vaccines project Nat Immunol 15 2014 589 592
100. L.L. He, D. Sok, P. Azadnia, J. Hsueh, E. Landais, M. Simek, W.C. Koff, D.R. Burton, and J. Zhu Towards a more accurate view of human B-cell repertoire by next-generation sequencing, unbiased repertoire capture and single-molecule barcoding Sci Rep 4 2014 6778